Membranous glomerulopathy (MG) is most commonly caused by autoantibodies directed against the podocyte phospholipase A2 receptor (PLA2R1) and common variants in this gene are associated with MG. Here for the first time, we carried out a large case-control association study (n = 1512) of PLA2R-positive and -negative MG to determine the extent of association in these pathologic subtypes. We performed four separate sets of analyses to determine significance of the single-nucleotide polymorphisms (SNPs) and their haplotypes followed by joint analysis and trans-ethnic mapping to increase power. The PLA2R1 SNP rs35771982 was most strongly associated with PLA2R-positive MG (P = 1.4 × 10 − 14 , odds ratio (OR GG ) = 1.98). The associations of other SNPs in PLA2R1 could be explained because of linkage disequilibrium with the G-allele. Haplotypes in PLA2R1 did not exceed the significance of rs35771982 even after 10 000 permutations. PLA2R1 variants were only associated with PLA2R-positive MG and predominantly in Caucasians. PLA2R1 variants did not associate with MG in African Americans (AA). There was strong epistasis between HLA-DQA1 SNP rs2187668 and the PLA2R1 variant rs35771982. Thus, common variants in the PLA2R1, particularly rs35771982, modulate PLA2R-positive MG with HLA-DQA1 in Caucasians. PLA2R-negative MG especially in AA, may provide a novel opportunity to discover new genes underlying MG.
INTRODUCTION
Membranous glomerulopathy (MG) is a morphologic pattern of glomerulonephritis in which immune complexes deposit along the subepithelial aspect of the glomerular basement membrane. It has long been known that there are numerous etiologies for this pattern of glomerulonephritis including autoimmune disease, infection and malignancy. The disease is termed primary when no known secondary etiologies are identified. The molecular pathogenesis for the majority of primary cases was uncovered only recently when it was shown that most patients with primary MG have autoantibodies directed against the podocyte phospholipase A2 receptor (PLA2R). 1 However, approximately 20-30% of primary MG cases are not PLA2R-associated and the antibody target remains unidentified. [2] [3] [4] The genetics of primary MG has been the subject of several recent publications, which have provided further validation that PLA2R1 has a role in this disease. One genome-wide association study has been performed in idiopathic MG, 5 which analyzed a total of 556 European patients. It found risk alleles in PLA2R1 and HLA-DQA1. Two smaller case-control genetic association studies from Asia also found association between idiopathic MG and alleles in PLA2R1. 6, 7 None of these studies differentiated between PLA2R-positive and -negative idiopathic MG. These studies raised the possibility that rare sequence variants in the PLA2R1 gene might be responsible for this disease. This question was addressed by Coenen et al. 8 who performed exonic sequencing of the PLA2R1 gene in 95 patients with idiopathic MG including 60 with PLA2R-associated MG. They concluded that rare variants are unlikely to explain the pathogenesis of idiopathic MG. They did find significant association between idiopathic MG and three non-synonymous single-nucleotide polymorphisms (SNPs). Recently, Lv et al. 9 performed a large case-control association study including 71 patients with known PLA2R status. They found an interaction between HLA-DQA1 and PLA2R1.
We have conducted a large case-control genetic association study of MG, which focuses on the PLA2R status of the MG. As such, we have assembled the largest cohort of PLA2R-positive MG (PLA2R+ MG) to date with 530 patients. Our aim was to determine if common variants in PLA2R1 or their combinations (haplotypes) defined the association signal for PLA2R1 in idiopathic MG and whether this was specific to a particular pathologic subtype viz PLA2R-positive MG or PLA2R-negative MG. We also sought to verify the significance of the previously identified HLA-DQA1 SNP rs2187668 in PLA2R-positive MG and PLA2R-negative and its interaction (epistasis) with PLA2R1 variants. Finally, we assessed the association of PLA2R1 variants in African Americans (AA), a group previously not investigated.
RESULTS

Patient characteristics
There was male preponderance in the PLA2R-positive MG group (67.7%), whereas there was a relatively balanced gender distribution in PLA2R-negative MG (M = 48.8%) and chronic kidney disease (CKD; M = 55.8%). Mean age in the overall data set was 53.6 ± 17 years and there was no difference in the three groups (analysis of variance, F = 1.51, P = 0.22). There were 53.8% Caucasians and 30.8% AA with generally equal distribution across all subsets. Other ethnicities included Hispanics (5.8%) and Asians (1.9%), whereas 7.4% samples were of unknown ethnicity. These were mostly clustered in the MG groups.
Genotype association
We initially performed a case-control association study of PLA2R+ MG cases with CKD controls (Group A) in Caucasians. PLA2R1 SNP rs35771982 strongly associated with PLA2R+ MG (χ 2 = 63.8, P = 1.44 × 10 − 14 , odds ratio (OR GG ) = 1.98 (1.67-2.36)). The associations of other SNPs in PLA2R1 could be explained due to linkage disequilibrium (LD) with the G-allele of rs35771982 as logistic regression analysis yielded an absence of interaction (Supplementary Table 1 ). Moreover, rs35771982 alleles were in Hardy-Weinberg (HW) equilibrium in controls (P = 0.83) but not in cases (P = 0.009), indicating a true association.
To determine whether the association with PLA2R1 variants was with PLA2R-positive MG only or with PLA2R-negative MG as well, PLA2R-positive MG was grouped as cases and compared against PLA2R-negative MG controls (group B). The association of rs35771982 decreased slightly but continued to be highly significant (χ 2 = 44.3, P = 2.4 × 10 − 10 , OR GG = 1.63). Again there was HW equilibrium in controls (P = 0.32) and not cases (P = 0.009). We then compared PLA2R-negative MG as cases with CKD controls and did not find any PLA2R1 SNP to be associated in Caucasians (group D; Supplementary Table 2 ). In this analysis, all PLA2R1 SNPs were in HW equilibrium in both cases and controls. These analyses demonstrated that PLA2R1 variants are only associated with PLA2R-positive MG.
We performed ethnicity-based analyses by assessing association in Caucasians and AA separately followed by a combined transethnic mapping ( Table 1) . The homogenous ethnicity analysis minimized the effect of population stratification, whereas the trans-ethnic mapping enhanced the effect of true associations. 10 As shown in Table 1 (all ethnicities sub-section), the association of rs35771982 in Caucasians decreased with the addition of other ethnicities in all analyses (groups A-C). This demonstrates that PLA2R1 variants predominantly influence the PLA2R-positive MG in Caucasians.
HLA-DQA1 SNP rs2187668 was strongly associated with MG in Caucasians; and when all ethnicities were combined (Table 1 ). In PLA2R-negative patients and AA, however, the association of rs2187668 was weak or absent (Table 1 and Supplementary Table  2) indicating that rs2187668 is also associated predominantly with PLA2R-positive MG in Caucasians.
Haplotype analysis To detect whether the association signal in PLA2R1 was modulated by variants other than those that we genotyped, we constructed haplotypes using PLINK and Haploview. LD plots were obtained for all analysis groups using Haploview (Figure 1 ). SNPs with r 2 40.8 were considered representing a single signal and the less significant SNP was removed from the haplotype analysis. PLINK sliding window haplotype analysis was also used to guide selection of variants to be included in the haploblock. The most significant haploblocks were evaluated for association in group C analysis ( Figure 1 ). In Caucasians (Figure 1a) , the most significant detrimental haplotype was ATG (F cases/controls = 0.60/0.40, P = 2.82 × 10
), whereas when all ethnicities were combined the haplotype GTG (F cases/controls = 0.69/0.57, P = 8.04 × 10
) was the most detrimental for PLA2R-positive MG ( Figure 1c ). In AA ( Figure 1b ) and in PLA2R-negative MG (Figure 1d ), no haplotype crossed the 10 000 permutation P-value to be significant. In spite of this rigorous procedure, none of the haplotypes exceeded the association of rs35771982 (Table 1 ) even after 10 000 permutations.
Epistasis
Fitting regression models suffer from the 'curse of dimensionality' because of power reduction from sparseness of data in high dimensions. Improved algorithms of detecting gene-gene interactions, such as multifactor dimensionality reduction (MDR), overcome these limitations by pooling genotypes into multilocus combinations of high-and low-risk groups to determine associations with disease. 11 In Caucasians, HLA-DQA1 SNP rs2187668 interacted strongly with PLA2R1 SNP rs35771982 (χ 2 = 13.2, P = 0.0003, OR = 7.46 (2.41-23.2), cross-validation consistency = 10 /10; Figure 2 ). When all PLA2R1 SNPs were considered in group A analysis in Caucasians rs2187668 interacted strongly with rs35771982 in a three SNP model (Table 2) . No epistasis was found in group D analyses. In AA, no epistasis was detected in group A analysis. This demonstrates that PLA2R1 modulates MG by interacting with HLA-DQA1 and this finding was specific for PLA2R + MG in Caucasians. Immunogenicity predication profile using the Jameson-Wolf method as encoded in DNASTAR software showed that the G-allele of rs35771982, which causes a substitution of the His at position 300 with Asp, increases the antigenic index in this region of the PLA2R protein (Supplementary Figure 2) .
DISCUSSION
A number of recent studies have sought to delineate the contribution of genetics to MG. Common variants in PLA2R1 and HLA-DQA1 were found to be associated with MG in several European and Asian populations. [5] [6] [7] 9 Recently, the PLA2R1 gene was screened for rare variants to determine whether these could potentially define the association, however, it was concluded that rare variants in the PLA2R1-coding sequence do not explain the pathogenesis of MG. 8 In this study, we sought to determine whether common variants in PLA2R1, their combination or rare haplotypes would define the genetic association with MG. Moreover, it is not clear whether the genetic association is directed toward PLA2R antibody-positive MG alone or encompasses PLA2R-negative disease as well. We have assimilated the largest collection to date of PLA2R-positive and -negative MG and evaluated the PLA2R1 and HLA-DQA1 associations separately in these phenotypic subtypes. So far, these associations have not been tested in the African American population and we assessed this as well. We also attempted to verify the postulate that HLA-DQA1 interacts with PLA2R1 to lead to autoantibody formation by triggering aberrant presentation of PLA2R epitopes.
We carried out a large case-control association study (n = 1512) with sub-phenotype analysis of PLA2R-positive (n = 530) and -negative MG (n = 426) and employed a modified genetic association study with controls without glomerular immune complex deposition (n = 556), on renal biopsy tissue samples. This allowed us to have pathologically well-defined phenotypes for a robust genetic evaluation. We performed four separate sets of analyses, as detailed above in Table 1 , to determine the significance of the SNPs and their haplotypes at the MG sub-phenotype level. This was followed by joint analysis of CKD controls with PLA2R-negative patients 12 and trans-ethnic mapping (by including all ethnicities in all four analyses) 13 to increase power.
We selected six SNPs spanning the PLA2R1 gene and attempted to capture its variation with LD. This strategy allowed us to determine the haplotypes across the gene to effectively localize the association signal in PLA2R1. In Caucasians, the PLA2R1 SNP rs35771982 was most strongly associated with PLA2R-positive MG (P = 1.4 × 10 − 14 , OR GG = 1.98) and its association was further increased in the joint analysis (P = 3.9 × 10 − 17 , OR GG = 2.45). We assessed the possibility of interaction between common PLA2R1 variants using logistic regression (Supplementary Table 1 ) and MDR epistasis algorithm to determine whether this mechanism would define the association with MG. However, as shown in Supplementary Tables 1 and 3 , the combined strength of association of rs35771982 decreased in proportion to the strength of association of the corresponding SNP. In fact, rs3749117 that was in full LD with rs35771982 and had the next best association with MG, when evaluated in combination nullified the entire association signal of itself and rs35771982 (Supplementary Table  1 ). This did not change when allelic association based genetic models (allelic, dominant, and recessive) were investigated (Supplementary Table 4 ). Haplotypes in PLA2R1 did not exceed the significance of rs35771982 even after 10 000 permutations, suggesting that this SNP may be the functional variant or in LD with it.
We found PLA2R1 variants to be specifically associated with PLA2R-positive MG. We used two independent analyses to reach this conclusion. First, we performed an association analysis of PLA2R-negative MG with CKD (Supplementary Table 2 ), which revealed absence of any association. Second, we attempted to annihilate the association signal of PLA2R-positive MG by using PLA2R-negative MG as controls. In this second analysis (Table 1 , group B), the association signal of PLA2R1 variants was only slightly diminished, indicating that PLA2R-negative MG was not modulated by PLA2R1 variants. Interestingly, rs35771982 remained the most significant SNP.
Our study confirmed the previously observed stronger association with HLA-DQA1 than with PLA2R1 variants. Interestingly, HLA-DQA1 SNP rs2187668 was strongly associated with PLA2R-positive MG, however, the strength of its association substantially decreased in PLA2R-negative MG (Supplementary Table 2 ). In AA, rs2187668 was associated with PLA2R-positive MG (Table 1) but not with PLA2R-negative MG (Supplementary Table 2 ). PLA2R1 SNPs were not found to be associated in AA with either PLA2R-positive MG or -negative MG. Possibly, the low frequency of the G-allele (7%) in this population combined with the smaller sample size did not provide adequate power to detect association. Alternatively, there is a possibility of the existence of as yet unknown genetic factors that underlie the pathogenesis of disease in AA especially PLA2R-negative MG. Figure 2 . MDR epistasis of HLA-DQA1 rs2187668 and PLA2R1 rs35771982 in Caucasians (Group A). Bars on the left represent the genotype combination counts in cases and those on the right are for controls. The diagram shows high counts in cases of HLA-DQA1 SNP rs2187668 AA or AG genotypes with PLA2R1 SNP rs35771982 GG or CG genotypes. This pattern is reversed for the combinations of rs2187668 GG as well as rs35771982 CC genotypes and generated high degree of interaction statistics (OR = 13.2). Abbreviations: CI, confidence interval; CV, cross-validation; MDR, multifactor dimensionality reduction; OR, odds ratio; SNP, single-nucleotide polymorphism. Note: HLA-DQA1 SNP (7) had the highest association signal, which increased further in the 3-SNP model (rs2187668/rs35771982/rs6757188). In the two SNP model, the best interaction was between SNP 7 and SNP 3, however, SNP 3 was not associated with MG (Table 1 ) and and as shown in Supplementary Table 3 , its interaction signal was mainly generated by SNP5 (rs35771982). Beyond the 3-SNP model the cross-validation consistency and interaction association statistics sharply dropped.
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In line with previous reports, 5 HLA-DQA1 SNP rs2187668 interacted strongly with PLA2R1 SNPs especially rs35771982, indicating that PLA2R1 variants likely modulate PLA2R-positive MG in association with HLA-DQA1 (Table 2) . HLA-DQA1 is part of a heterodimer consisting of an alpha chain (DQA) and a beta chain (DQB), both anchored in the membrane and forming the antigenpresenting groove. As previously suggested, 5 HLA-DQA1 could alter the presentation of PLA2R epitopes resulting in an aberrant immune response. A model of the sequence change introduced by rs35771982 showed that the G-allele increased the immunogenicity of PLA2R (Supplementary Figure 2) . It may be possible that the G-allele of the rs35771982 (Asp 300 ) variant introduces a conformational change in the protein, triggering an autoimmune response, enhanced by the presence of HLA-DQA1. This may lead to the generation of pathogenic PLA2R autoantibodies and the development of MG.
In summary, our findings indicate that both PLA2R1 and HLA-DQA1 predominantly influence PLA2R-positive MG in Caucasians perhaps mediated through the SNP rs35771982. This study has elucidated that PLA2R-negative MG especially in AA, provides a novel opportunity to discover new genes underlying MG, although this finding will need further verification with larger sample sizes of AA MG patients. To date, our study is the largest cohort of PLA2R-positive MG patients, defined by immunofluorescence and electron microscopy on kidney biopsy samples. Moreover, we present here a major comparison between histopathologically defined PLA2R+ and PLA2R − MG cases, which helps refine the underlying genetics of these two sub-phenotypes. Our study also provides a more robust verification of gene × gene interaction between HLA-DQA1 and PLA2R1 and postulates that the D300 variant (Aspartate coded by the G-allele of rs35771982) in PLA2R may interact with HLA-DQA1 to lead to the development of MG.
MATERIALS AND METHODS
Our data set consisted of 1512 renal biopsies divided into three groups: PLA2R-positive MG cases (n = 530; Caucasians = 280 and AA = 115) and controls comprised of PLA2R-negative MG (n = 426; Caucasians = 196 and AA = 128) and CKD (n = 556; Caucasians = 337 and AA = 218). The ethnicity was patient-reported and some patients did not report it. Other ethnicities included Hispanics, South Asians, East Asians and Native Americans and so on. PLA2R status was determined by immunofluorescence evaluation on the renal biopsy as previously described. 3 The data were collected according to protocols approved by Schulman Institutional Review Board and met Health Insurance Portability and Accountability Act standards of confidentiality and disclosure.
Genotyping
Our SNP selection strategy was based on (a) review of literature with an attempt to include previously associated SNPs, (b) LD across PLA2R1, (c) evolutionary conservation of gene segments. We identified 20 SNPs previously reported in the literature to have been investigated in PLA2R1.
5-9 Six of these SNPs had minor allele frequencies o0.05 and were not included for genotyping. Using the UCSC database, we found exons 2-8, 10-17, 21 and 22, 24-27 and 29 to be evolutionary conserved. SNPs previously genotyped were not included if they had minor allele frequencies o 0.05, were intronic and in an already covered region by another exonic SNP (for example, rs4664308), located in the nonevolutionary conserved region of PLA2R1 or synonymous coding SNPs (for example, rs4665143). Based on the LD pattern in Caucasians, we determined six SNPs spanning the PLA2R1 gene and across the evolutionary conserved exons to be the most useful for association mapping (Supplementary Figure 2) . Our careful SNP selection utilized here provided adequate coverage of PLA2R1 by tagging SNPs, which are strategically located in evolutionary conserved regions not only in Caucasians but also in AA (Figure 1b) . DNA was extracted from tissue samples using the QIAamp DNA mini kit (Qiagen, Valencia, CA, USA). The DNA concentration of each sample was determined using the Nanodrop 8000 (Thermo Scientific, Wilmington, DE, USA). Genotyping was performed on the ViiA 7 Real-Time PCR System in 5 μl reaction in 384-well plates using the 2X genotyping master mix (Life Technologies, Carlsbad, CA, USA) and 20X genotyping primer/probes synthesized by Life Technologies. On each plate, 10 no template controls were genotyped with the samples. Each run was checked for accuracy of calls in the controls and samples. Genotyping data were analyzed in the ViiA7 sequence detection software v2.0. Amplification plots were assessed for correct genotyping calls. There was 495% genotype call rate.
Statistical analyses
We designed a modified case-control study using a pathologically welldefined phenotype, that is, PLA2R antibody-positive MG and diseased controls. There is precedence for the successful application of this method for gene discovery. 14, 15 Our first set of controls was PLA2R-negaitve MG, whereas the second set of controls was CKD without glomerular immune complex deposition. We performed analyses in four groups: (a) PLA2R-positive MG as cases with CKD controls; (b) PLA2R-positive MG cases with PLA2R-negative MG as controls; (c) PLA2R-positive MG cases against a joint PLA2R-negative MG and CKD controls; (d) PLA2R-negative MG as cases with CKD controls. Association statistics were determined in Caucasians and African Americans separately followed by a combined analysis of all ethnicities. This approach of trans-ethnic mapping has been shown to increase power to detect associations. 10, 13 Clinical and genotype data for all SNPs were entered into a database in SPSS (Statistical Package for Social Sciences) Software Version 20.0 for Windows (Gorinchem, The Netherlands) and analyzed for genetic association. Genotype associations were assessed by χ 2 analyses. Data organized in SPSS was exported in PLINK/Haploview formats for further analysis. Estimations of departures from HW equilibrium were calculated by χ 2 test in PLINK. 16 Haplotype frequencies and association statistics as well as LD plots were generated using Haploview. 17 Sliding window haplotype analysis was performed using PLINK. Both analyses were used to detect the best combination of SNPs for determining the most significantly associated haplotypes. Epistasis (geneχgene interaction) was performed using MDR analysis. 17, 18 Nominal P values were adjusted for multiple testing using Bonferroni and false discovery rate 19 corrections to determine absolute significance with Po0.01 as the cutoff. We applied the Jameson-Wolf predictive algorithm (DNASTAR Protean 3D program) to determine the antigenic index (immunogenicity) of PLA2R1 variants. The antigenic index is a measure of the probability that a domain is antigenic and is calculated by summing weighted values for surface accessibility, regional backbone flexibility and certain features of predicted secondary structure. 20 
